Normal view MARC view ISBD view

Evaluation and Treatment of Febrile Ulceronecrotic Mucha-Habermann Disease With Ruxolitinib and Tocilizumab as Guided by Cytokine Profile.

Evaluation and Treatment of Febrile Ulceronecrotic Mucha-Habermann Disease With Ruxolitinib and Tocilizumab as Guided by Cytokine Profile. - 2021

English

ISSN: 2168-6068

Standard No.: 10.1001/jamadermatol.2021.4047 [doi] 2785019 [pii]

Subjects--Topical Terms:
*Pityriasis Lichenoides
Antibodies, Monoclonal, Humanized
Cytokines
Herpes Simplex
Humans
Nitriles
Pityriasis Lichenoides/th [Therapy]
Pyrazoles
Pyrimidines

Subjects--Geographic Terms:
MedStar Washington Hospital Center

Index Terms--Occupation:
Medical Dermatology Residency

Index Terms--Function:
Journal Article

Print
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)